Aryl hydrocarbon receptor ligand production by the gut microbiota is decreased in celiac disease leading to intestinal inflammation DOI

Bruno Lamas,

Leticia Hernández-Galán,

Heather J. Galipeau

et al.

Science Translational Medicine, Journal Year: 2020, Volume and Issue: 12(566)

Published: Oct. 21, 2020

Metabolism of tryptophan by the gut microbiota into derivatives that activate aryl hydrocarbon receptor (AhR) contributes to intestinal homeostasis. Many chronic inflammatory conditions, including celiac disease involving a loss tolerance dietary gluten, are influenced cues from microbiota. We investigated whether AhR ligand production could influence gluten immunopathology in nonobese diabetic (NOD) mice expressing DQ8, susceptibility gene. NOD/DQ8 mice, exposed or not were subjected three interventions directed at enhancing pathway activation. These included high-tryptophan diet, gavage with Lactobacillus reuteri produces ligands treatment an agonist. permeability, composition determined 16S rRNA gene sequencing, activation contents, and small pathology markers. In diet modulated enhanced production. enriched producer L. reuteri, pharmacological stimulation using 6-formylindolo (3,2-b) carbazole (Ficz) decreased gluten. then fecal patients active compared nonceliac control individuals. Patients demonstrated reduced lower results highlight microbiota-dependent modulation suggest new therapeutic strategy for treating this disorder.

Language: Английский

Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases DOI Creative Commons
Theodore S. Kapellos, Lorenzo Bonaguro, Ioanna D. Gemünd

et al.

Frontiers in Immunology, Journal Year: 2019, Volume and Issue: 10

Published: Aug. 30, 2019

Human monocytes are divided in three major populations; classical (CD14+CD16-), non-classical (CD14dimCD16+), and intermediate (CD14+CD16+). Each of these subsets is distinguished from each other by the expression distinct surface markers their functions homeostasis disease. In this review, we discuss most up-to-date phenotypic classification human that has been greatly aided application novel single-cell transcriptomic mass cytometry technologies. Furthermore, shed light on role plastic immune cells already recognized emerging chronic diseases, such as obesity, atherosclerosis, obstructive pulmonary disease, lung fibrosis, cancer, Alzheimer's Our aim to provide an insight into contribution progression diseases highlight candidacy potential therapeutic cell targets.

Language: Английский

Citations

693

Astrocyte Crosstalk in CNS Inflammation DOI Creative Commons
Mathias Linnerbauer, Michael A. Wheeler, Francisco J. Quintana

et al.

Neuron, Journal Year: 2020, Volume and Issue: 108(4), P. 608 - 622

Published: Sept. 7, 2020

Language: Английский

Citations

661

Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor DOI Open Access
Samantha A. Scott, Jingjing Fu, Pamela V. Chang

et al.

Proceedings of the National Academy of Sciences, Journal Year: 2020, Volume and Issue: 117(32), P. 19376 - 19387

Published: July 27, 2020

Significance The gut microbiome comprises trillions of microorganisms that inhabit the mammalian intestines. These microbes regulate many aspects host physiology, including defense mechanisms against factors contribute to inflammatory bowel diseases (IBDs). Despite abundance microbiota, little is known regarding how these modulate processes, barrier function intestinal epithelium, which controls permeability associated with IBDs. Here, we discover three microbially produced, small-molecule metabolites, derive from dietary tryptophan, improve integrity and protect inflammation caused by Our studies identify a receptor downstream targets could serve as potential pathways for prophylactic therapeutic treatments ameliorating morbidity in

Language: Английский

Citations

427

IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression DOI Creative Commons
Ahmed Sadik, Luis F. Somarribas Patterson, Selcen Öztürk

et al.

Cell, Journal Year: 2020, Volume and Issue: 182(5), P. 1252 - 1270.e34

Published: Aug. 19, 2020

Aryl hydrocarbon receptor (AHR) activation by tryptophan (Trp) catabolites enhances tumor malignancy and suppresses anti-tumor immunity. The context specificity of AHR target genes has so far impeded systematic investigation activity its upstream enzymes across human cancers. A pan-tissue signature, derived natural language processing, revealed that 32 entities, interleukin-4-induced-1 (IL4I1) associates more frequently with than IDO1 or TDO2, hitherto recognized as the main Trp-catabolic enzymes. IL4I1 activates through generation indole metabolites kynurenic acid. It reduced survival in glioma patients, promotes cancer cell motility, adaptive immunity, thereby enhancing progression chronic lymphocytic leukemia (CLL) mice. Immune checkpoint blockade (ICB) induces IL4I1. As inhibitors do not block IL4I1, may explain failure clinical studies combining ICB inhibition. Taken together, opens new avenues for therapy.

Language: Английский

Citations

382

Function and therapeutic value of astrocytes in neurological diseases DOI
Hong‐Gyun Lee, Michael A. Wheeler, Francisco J. Quintana

et al.

Nature Reviews Drug Discovery, Journal Year: 2022, Volume and Issue: 21(5), P. 339 - 358

Published: Feb. 16, 2022

Language: Английский

Citations

364

Microglia and Central Nervous System–Associated Macrophages—From Origin to Disease Modulation DOI
Marco Prinz, Takahiro Masuda, Michael A. Wheeler

et al.

Annual Review of Immunology, Journal Year: 2021, Volume and Issue: 39(1), P. 251 - 277

Published: Feb. 9, 2021

The immune system of the central nervous (CNS) consists primarily innate cells. These are highly specialized macrophages found either in parenchyma, called microglia, or at CNS interfaces, such as leptomeningeal, perivascular, and choroid plexus macrophages. While they were thought phagocytes, their function extends well beyond simple removal cell debris during development diseases. Brain-resident cells to be plastic, long-lived, host an outstanding number risk genes for multiple pathologies. As a result, now considered most suitable targets modulating Additionally, recent single-cell technologies enhanced our molecular understanding origins, fates, interactomes, functional statesduring health perturbation. Here, we review current state challenges myeloid biology treatment options related

Language: Английский

Citations

353

The aryl hydrocarbon receptor as a target of environmental stressors – Implications for pollution mediated stress and inflammatory responses DOI Creative Commons
Christoph F.A. Vogel, Laura S. Van Winkle, Charlotte Esser

et al.

Redox Biology, Journal Year: 2020, Volume and Issue: 34, P. 101530 - 101530

Published: April 18, 2020

The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor regulating the expression of genes, for instance encoding monooxygenases cytochrome P450 (CYP) 1A1 and CYP1A2, which are important enzymes in metabolism xenobiotics. AHR activated upon binding polycyclic aromatic hydrocarbons (PAHs), persistent organic pollutants (POPs), related ubiquitous environmental chemicals, to mediate their biological toxic effects. In addition, several endogenous natural compounds can bind AHR, thereby modulating variety physiological processes. recent years, ambient particulate matter (PM) associated with traffic air pollution (TRAP) has been found contain significant amounts PAHs. PM containing PAHs increasing concern as class agonists, activate AHR. Several reports show that AHR-mediated induction CYP1A1 results excessive generation reactive oxygen species (ROS), causing oxidative stress. Furthermore, exposure induce inflammatory responses may lead chronic diseases, including asthma, cardiovascular increased cancer risk. this review, we summarize findings showing critical role plays mediating effects stressors, pose risk impacting environment human health.

Language: Английский

Citations

332

A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders DOI
Shokufeh Ghasemian Sorboni,

Hanieh Shakeri Moghaddam,

Reza Jafarzadeh Esfehani

et al.

Clinical Microbiology Reviews, Journal Year: 2022, Volume and Issue: 35(1)

Published: Jan. 5, 2022

The human body is full of an extensive number commensal microbes, consisting bacteria, viruses, and fungi, collectively termed the microbiome. initial acquisition microbiota occurs from both external maternal environments, vast majority them colonize gastrointestinal tract (GIT). These microbial communities play a central role in maturation development immune system, nervous GIT system are also responsible for essential metabolic pathways. Various factors, including host genetic predisposition, environmental lifestyle, diet, antibiotic or nonantibiotic drug use, etc., affect composition gut microbiota. Recent publications have highlighted that imbalance microflora, known as dysbiosis, associated with onset progression neurological disorders. Moreover, characterization microbiome-host cross talk pathways provides insight into novel therapeutic strategies. Novel preclinical clinical research on interventions related to microbiome treating conditions, autism spectrum disorders, Parkinson's disease, schizophrenia, multiple sclerosis, Alzheimer's epilepsy, stroke, hold significant promise. This review aims present comprehensive overview potential involvement pathogenesis particular emphasis microbe-based therapies and/or diagnostic biomarkers. discusses health benefits administration probiotics, prebiotics, postbiotics, synbiotics fecal transplantation

Language: Английский

Citations

324

Inhibition and induction of CYP enzymes in humans: an update DOI Creative Commons
Jukka Hakkola, Janne Hukkanen, Miia Turpeinen

et al.

Archives of Toxicology, Journal Year: 2020, Volume and Issue: 94(11), P. 3671 - 3722

Published: Oct. 27, 2020

Abstract The cytochrome P450 (CYP) enzyme family is the most important system catalyzing phase 1 metabolism of pharmaceuticals and other xenobiotics such as herbal remedies toxic compounds in environment. inhibition induction CYPs are major mechanisms causing pharmacokinetic drug–drug interactions. This review presents a comprehensive update on inhibitors inducers specific CYP enzymes humans. focus more recent human vitro vivo findings since publication our previous this topic 2008. In addition to general presentation inhibitory drugs by drugs, remedies, compounds, an in-depth view tyrosine-kinase antiretroviral HIV medications victims perpetrators interactions provided examples current trends field. Also, concise overview presented aid understanding phenomena.

Language: Английский

Citations

282

Neuronal programming by microbiota regulates intestinal physiology DOI
Yuuki Obata, Álvaro Castaño, Stefan Boeing

et al.

Nature, Journal Year: 2020, Volume and Issue: 578(7794), P. 284 - 289

Published: Feb. 5, 2020

Language: Английский

Citations

275